Technical Analysis for AXGT - Axovant Sciences Ltd.

Grade Last Price % Change Price Change
grade D 1.395 -3.13% -0.05
AXGT closed up 0.7 percent on Thursday, March 21, 2019, on 45 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical AXGT trend table...

Date Alert Name Type % Chg
Mar 21 20 DMA Support Bullish -3.13%
Mar 21 Stochastic Buy Signal Bullish -3.13%
Mar 21 Narrow Range Bar Range Contraction -3.13%
Mar 21 Wide Bands Range Expansion -3.13%
Mar 21 Up 3 Days in a Row Strength -3.13%
Mar 21 Oversold Stochastic Weakness -3.13%
Mar 20 Crossed Above 20 DMA Bullish -2.45%
Mar 20 Narrow Range Bar Range Contraction -2.45%
Mar 20 Wide Bands Range Expansion -2.45%
Mar 20 Gapped Up Strength -2.45%

Older signals for AXGT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Axovant Sciences is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurological and neuromuscular diseases. The company’s current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), Parkinson’s disease, oculopharyngeal muscular dystrophy (OPMD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.
Rare Diseases Gene Therapy Amyotrophic Lateral Sclerosis Oculopharyngeal Muscular Dystrophy Lipid Storage Disorders Parkinson’s Disease Axovant Sciences Frontotemporal Dementia Gangliosidosis Gm1 Gm1 Gangliosidosis Gm2 Gangliosidoses Gm 2 Gangliosidosis Gm2 Gangliosidosis Neurological And Neuromuscular Diseases Sandhoff Disease Tay Sachs Disease Tay–Sachs Disease
Is AXGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.59
52 Week Low 0.93
Average Volume 2,722,285
200-Day Moving Average 1.9387
50-Day Moving Average 1.2447
20-Day Moving Average 1.4355
10-Day Moving Average 1.519
Average True Range 0.1513
ADX 40.97
+DI 39.4061
-DI 18.2513
Chandelier Exit (Long, 3 ATRs ) 1.9961
Chandelier Exit (Short, 3 ATRs ) 1.6239
Upper Bollinger Band 1.7049
Lower Bollinger Band 1.1661
Percent B (%b) 0.51
BandWidth 37.53396
MACD Line 0.0575
MACD Signal Line 0.0757
MACD Histogram -0.0181
Fundamentals Value
Market Cap 154.84 Million
Num Shares 108 Million
EPS -2.10
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 0.00
Price-to-Book 2.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.55
Resistance 3 (R3) 1.54 1.50 1.53
Resistance 2 (R2) 1.50 1.47 1.50 1.52
Resistance 1 (R1) 1.47 1.46 1.49 1.48 1.52
Pivot Point 1.43 1.43 1.44 1.43 1.43
Support 1 (S1) 1.40 1.40 1.42 1.41 1.36
Support 2 (S2) 1.36 1.39 1.36 1.36
Support 3 (S3) 1.33 1.36 1.35
Support 4 (S4) 1.34